TRACON Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LPL FINANCIAL LLC | 05/10/2024 | 450.65 K | $193.69 K | 100.00% | 1.38% |
ACADIAN ASSET MANAGEMENT LLC | 05/10/2024 | 413.91 K | $176.00 K | 0.00% | 1.26% |
SQUAREPOINT OPS LLC | 05/15/2024 | 388.99 K | $167.19 K | -5.65% | 1.19% |
RENAISSANCE TECHNOLOGIES LLC | 05/13/2024 | 300.24 K | $129.00 K | 206.25% | 0.92% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2024 | 286.71 K | $123.23 K | 37.32% | 0.88% |
VANGUARD GROUP INC | 05/10/2024 | 262.77 K | $112.94 K | 0.00% | 0.80% |
BLACKROCK INC. | 05/10/2024 | 260.08 K | $111.78 K | -0.45% | 0.79% |
JANE STREET GROUP, LLC | 05/16/2024 | 182.31 K | $78.36 K | 100.00% | 0.56% |
UBS GROUP AG | 05/13/2024 | 91.33 K | $39.27 K | 100.00% | 0.28% |
JOHNSON & JOHNSON | 05/10/2024 | 84.00 K | $36.10 K | 0.00% | 0.26% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/07/2024 | 77.87 K | $33.47 K | 100.00% | 0.24% |
STATE STREET CORP | 05/15/2024 | 75.15 K | $32.30 K | 0.00% | 0.23% |
MILLENNIUM MANAGEMENT LLC | 05/15/2024 | 74.66 K | $32.09 K | -61.00% | 0.23% |
CI PRIVATE WEALTH, LLC | 05/09/2024 | 57.46 K | $24.70 K | 0.00% | 0.18% |
HRT FINANCIAL LP | 05/13/2024 | 54.36 K | $23.00 K | 100.00% | 0.17% |
TWO SIGMA INVESTMENTS, LP | 05/15/2024 | 34.82 K | $14.97 K | 100.00% | 0.11% |
XTX TOPCO LTD | 05/13/2024 | 27.97 K | $12.02 K | 100.00% | 0.09% |
ETF PORTFOLIO PARTNERS, INC. | 05/03/2024 | 24.64 K | $10.59 K | 100.00% | 0.08% |
SPIDERROCK ADVISORS, LLC | 04/30/2024 | 22.98 K | $8.30 K | 100.00% | 0.07% |
NORTHERN TRUST CORP | 05/14/2024 | 21.69 K | $9.32 K | 0.00% | 0.07% |
HOYLECOHEN, LLC | 05/15/2024 | 13.00 K | $5.59 K | 0.00% | 0.04% |
JUMP FINANCIAL, LLC | 05/13/2024 | 10.50 K | $4.52 K | 100.00% | 0.03% |
BANK OF NEW YORK MELLON CORP | 04/25/2024 | 10.26 K | $4.41 K | 0.00% | 0.03% |
MERCER GLOBAL ADVISORS INC /ADV | 05/15/2024 | 10.00 K | $4.00 K | 100.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2024 | 7.58 K | $3.26 K | -26.88% | 0.02% |
GAME PLAN FINANCIAL ADVISORS, LLC | 04/12/2024 | 1.00 K | $430 | 0.00% | 0.00% |
TRUVESTMENTS CAPITAL LLC | 05/14/2024 | 318 | $137 | 0.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/10/2024 | 207 | $89 | 1.47% | 0.00% |
MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
GTS SECURITIES LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2024 | 0 | $0 | -100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
IKARIAN CAPITAL, LLC | 05/17/2024 | 0 | $0 | -100.00% | 0.00% |
TRACON Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of TRACON Pharmaceuticals, Inc.. The most heavily invested institutionals were:
HoyleCohen, LLC: 0
BlackRock Inc.: 0
Telemetry Investments, L.L.C.: 97,000
DOWLING & YAHNKE LLC: 47,455
ACT CAPITAL MANAGEMENT, LLC: 28,500
Psagot Value Holdings Ltd.: 143,591
9.91% of TRACON Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 444.28 K shares in the last 24 months. This purchase volume represents approximately $0 in transactions.